Yield Endurance Strategic Partner Closes on Initial Loan of 110 Bitcoins
May 02, 2018 12:51 pm UTC| Business
JERSEY CITY, N.J., May 02, 2018 -- Sport Endurance, Inc. (OTCQB:SENZ) (the “Company”) wholly-owned subsidiary, Yield Endurance, Inc. (the “Subsidiary”), today announced that its strategic business partner, Madison...
Aeris Mobility Platform to Simplify Delivery of Complex IoT Services
May 02, 2018 12:51 pm UTC| Business
SAN JOSE, Calif., May 02, 2018 -- Aeris, a technology leader in the Internet of Things (IoT), today announced it has published a white paper written by a leading IoT analyst firm, Strategy Analytics, which documents how...
Calian to Hold Conference Call Following Announcement of Second Quarter Results
May 02, 2018 12:49 pm UTC| Business
OTTAWA, May 02, 2018 -- Calian Group Ltd. (TSX:CGY) will hold a telephone conference call at 2:00 p.m. eastern time on Wednesday, May 9, 2018 to discuss the results for the period ended March 31, 2018, which will be...
Magna5 Achieves Highly-Coveted Premier Status among Commvault Service Provider
May 02, 2018 12:45 pm UTC| Business
DALLAS, May 02, 2018 -- Business continuity is paramount for businesses to remain agile and resilient in the face of escalating cyber threats and for executing digital transformation. Magna5, a NewSpring Holdings’...
SELLAS Life Sciences Completes Second Tranche of $10,700,000 Private Placement
May 02, 2018 12:45 pm UTC| Business
NEW YORK, May 02, 2018 -- SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) (“SELLAS” or “the Company”), a clinical-stage biopharmaceutical company focused on novel cancer immunotherapies for a broad range of cancer...
Over 200,000 Images Documenting History of Early America and U.S. Westward Expansion Now Online
May 02, 2018 12:45 pm UTC| Business
Chicago, May 02, 2018 -- For decades, the Newberry has been a physical destination for the study of early America and the westward expansion of the United States. And it's increasingly becoming a digital destination as...
May 02, 2018 12:44 pm UTC| Business
FREMONT, Calif., May 02, 2018 -- Asterias Biotherapeutics, Inc. (NYSE MKT:AST), a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions associated with demyelination and...